Daniel E. Geffken
Interim CFO at CalciMedica, Inc. (CALC) since March 2023
Daniel E. Geffken has filed 12 insider reports with the SEC since February 2021, as interim CFO at CalciMedica, Inc. (CALC), chief Financial Officer at Cero Therapeutics Holdings, Inc. (CERO) and officer at ProMIS Neurosciences Inc. (PMN) and at 2 more companies. Daniel E. Geffken made no open-market purchases or sales in the last 12 months. The latest filing, on May 20, 2024, reports grant or award at CalciMedica, Inc. (CALC).
- Filings
- 12
- Companies
- 5
- Bought on market
- $36K
- Sold on market
- None
Companies where Daniel E. Geffken is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Interim CFOsince March 2023 | $1.22 | May 20, 2024 | |||||
| Chief Financial Officer | 10,002 | $0.0951 | Feb 17, 2024 | ||||
| Officer | $3.21 | Oct 30, 2023 | |||||
| Director | 2,175 | Aug 29, 2023 | |||||
| Officersince April 2021 | 50,000 | $36K | $0.72 | $11.74+1531% | Dec 1, 2021 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- May 17, 2024CALCSEC Form 4 filed by Geffken Daniel E.Form 4Grant or award
- Feb 14, 2024CEROGeffken Daniel E. acquired 10,002 sharesForm 4Other acquisition or disposition
- Oct 26, 2023PMNSEC Form 4 filed by Geffken Daniel E.Form 4Grant or award
- Aug 23, 2023WINTSEC Form 4: Geffken Daniel E. was granted 2,033 shares, increasing direct ownership by 1,432% to 2,175 unitsForm 4Grant or award
- Mar 20, 2023CALCSEC Form 4 filed by Geffken Daniel E.Form 4Grant or award
- Mar 20, 2023CALCDaniel E. Geffken became an insiderForm 3New insider
- Jun 7, 2022WINTSEC Form 4: Geffken Daniel E. was granted 5,000 shares, increasing direct ownership by 242% to 7,069 unitsForm 4Grant or award
- Nov 29, 2021+$36KELOXSEC Form 4: Geffken Daniel E. bought $36,000 worth of shares (50,000 units at $0.72)Form 4Open-market purchase
- Jun 15, 2021WINTSEC Form 4 filed by Geffken Daniel E.Form 4Grant or award
- Apr 20, 2021ELOXSEC Form 4 filed by Geffken Daniel E.Form 4Grant or award
- Apr 1, 2021ELOXSEC Form 3 filed by E. Daniel GeffkenForm 3New insider
- Feb 3, 2021WINTSEC Form 4 filed by E. Daniel GeffkenForm 4Grant or award
Also sits on boards with
Officers and directors who share two or more companies with Daniel E. Geffken.
Compare Daniel E. Geffken with
- Daniel E. Geffken vs Andrew Albert Kucharchuk2 shared
- Daniel E. Geffken vs Eugene Williams1 shared
- Daniel E. Geffken vs Eric W Roberts1 shared
- Daniel E. Geffken vs Neil Cashman1 shared
- Daniel E. Geffken vs Kenneth A. Stauderman1 shared
- Daniel E. Geffken vs Sudarshan Hebbar1 shared
Other insiders at the same companies
- Eugene WilliamsPMN
- Eric W RobertsCALC
- Neil CashmanPMN
- Kenneth A. StaudermanCALC
- Sudarshan HebbarCALC
- Stephen BardinCALC
- A. Rachel LehenyCALC
- Alafi Capital Co LLCCALC
- Allan ShawCALC
- Alan GlicklichCALC
- Frederic GuerardCALC
- Evgeny ZaytsevCALC
- Robert N WilsonCALC
- Johanne KaplanPMN
- Fred A MiddletonCALC
- Domicilium Real Estate Fund III LPELOX
Questions about Daniel E. Geffken
- What is Daniel E. Geffken's role at CalciMedica, Inc.?
- Daniel E. Geffken reports to the SEC as interim CFO at CalciMedica, Inc. (CALC), according to the latest filing on May 20, 2024. Daniel E. Geffken has also filed as chief Financial Officer at Cero Therapeutics Holdings, Inc. (CERO), officer at ProMIS Neurosciences Inc. (PMN), director at Windtree Therapeutics Inc /de/ (WINT) and officer at Eloxx Pharmaceuticals, Inc. (ELOX).
- How many shares does Daniel E. Geffken own?
- After the latest filing that states it, Daniel E. Geffken directly owned 10,002 shares of Cero Therapeutics Holdings, Inc. (CERO), 2,175 shares of Windtree Therapeutics Inc /de/ (WINT) and 50,000 shares of Eloxx Pharmaceuticals, Inc. (ELOX). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Daniel E. Geffken bought or sold stock recently?
- The most recent open-market purchase was on November 29, 2021: bought 50,000 shares of Eloxx Pharmaceuticals, Inc. (ELOX) for $36K at an average of $0.72.
- How do I get alerts when Daniel E. Geffken files?
- Follow Daniel E. Geffken on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Daniel E. Geffken (SEC CIK 0001314756). Totals count each trade once, skipping amendments whose original is on file, from Feb 6, 2021 on. View on SEC EDGAR